鼻内镜鼻腔泪囊造口术治疗慢性泪囊炎78例

目的探讨鼻内窥镜行鼻腔泪囊造口术治疗慢性泪囊炎的手术方法及临床疗效。方法对62例（78眼）慢性泪囊炎患者采用鼻内窥镜行鼻腔泪囊造口术治疗,术后随访6-24个月观察手术疗效。结果78眼中治愈69眼,好转8眼．无效1眼,有效率为98．72％。结论鼻内窥镜行鼻腔泪囊造口术可有效治疗慢性泪囊炎。     

鼻内窥镜下泪囊鼻腔造口术治疗慢性泪囊炎

目的:探讨鼻内窥镜直视下泪囊鼻腔造口术治疗慢性泪囊炎的临床疗效。方法:30例慢性泪囊炎患者,接受了鼻腔内窥镜下的泪囊鼻腔造口术。其中13例合并鼻腔病变(7例鼻中隔偏曲,6例中鼻甲肥大),同期也进行了相应的手术治疗。手术方法:使用0°或30°硬性鼻内窥镜,采用去除骨质、切除泪囊内壁的方法,实施经鼻泪囊鼻腔造口术。结果:30例患者治愈27例(占90％),好转2例(占6.7％),无效1例(占3.3％),有效率达96.7％。结论:鼻内窥镜下泪囊鼻腔造口术,可避免面部切口,术中可检查鼻内解剖状况,进行必要的处理,减少传统手术常见的失败原因,在临床上有广阔的应用前景。     

鼻内镜下鼻腔泪囊造口术治疗慢性泪囊炎的临床研究

目的：：观察鼻内镜下鼻腔泪囊造口术治疗慢性泪囊炎的疗效并探讨手术操作技巧。方法：回顾分析鼻内镜下鼻腔泪囊造口术治疗的慢性泪囊炎患者140例169眼,对随访6~12 mo的临床资料进行总结和分析,评价治疗效果并探讨鼻内镜下鼻腔泪囊造口术治疗慢性泪囊炎的手术技巧。结果：本组痊愈155眼(91.7％),好转3眼(1.8％),无效11眼(6.5％),总有效率93.5％,与传统泪囊鼻腔吻合术组术后疗效比较,无显著性差异(χ2=3.743,P>0.05)。结论：鼻内镜下鼻腔泪囊造口术治疗慢性泪囊炎有较好的治疗效果。泪囊的定位及大小、造口位置及大小、造口黏膜瓣的处理、鼻部疾病的处理等操作技巧、术后随访及处理和患者体质均可能影响手术疗效。     

内窥镜下鼻内泪囊鼻腔造口术治疗慢性泪囊炎

慢性泪囊炎治疗主要是采取外切口的传统泪囊鼻腔吻合术。近年来，鼻内镜下治疗慢性泪囊炎已成为鼻眼相关外科的重要内容之一。2002年1月～2003年2月我院开展鼻内镜下鼻腔泪囊造口术治疗慢性泪囊炎，取得良好疗效。     

鼻内镜下泪囊鼻腔造口术治疗慢性泪囊炎78例

本科采用鼻内镜下泪囊鼻腔造口术治疗慢性泪囊炎78例,现报告如下。 1资料与方法     

经鼻内镜泪囊鼻腔造口术治疗慢性泪囊炎21例

慢性泪囊炎是眼科常见病,以农村最为多见。以往一般经鼻外切121行鼻腔泪囊吻合术,操作复杂,创伤大,易遗留面部瘢痕。我科自2005年1月至2007年5月经鼻内镜行鼻腔泪囊造口术治疗慢性泪囊炎21例（27眼）,效果良好,现报告如下。     

改良鼻内窥镜下泪囊鼻腔造口术

目的 探讨改良鼻内窥镜下泪囊鼻腔造口术治疗慢性泪囊炎的临床效果。方法 采用泪囊鼻腔造口C形置管术治疗慢性泪囊炎42例(42眼)。对伴上泪道阻塞者用自制的头端略呈锥形泪道探针，按泪道探通方向突破阻塞部位11眼。结果 42眼术后全部治愈，拔管后溢泪、溢脓症状消失，泪道冲洗通畅。结论 改良鼻内窥镜下泪囊鼻腔造口术能较好地解决伴上泪道阻塞的慢性泪囊炎；C形置管使手术效果更为可靠。     

鼻内镜下泪囊鼻内造口术治疗慢性泪囊炎的临床探讨

目的:探讨鼻内镜下泪囊鼻内造口术治疗24例慢性泪囊炎患者的临床术式与疗效。方法:针对24例26眼慢性泪囊炎,行鼻内窥镜下泪囊鼻内造口术,其中对于14眼(8眼Ⅰ型和6眼Ⅱ型)行单纯泪囊鼻腔造口术,12眼(6眼Ⅱ型和6眼Ⅲ型)行泪囊-筛窦-鼻腔造口术。结果:19眼治愈,6眼好转,1眼无效,无效者为合并有慢性鼻窦炎行上颌窦根治术。结论:鼻内镜下泪囊鼻内造口术治疗慢性泪囊炎具有良好疗效,但对于不同类型的泪囊窝,需依据术前泪囊CT造影实施不同的术式。     

鼻内镜下泪囊鼻腔造口术的疗效分析

目的观察鼻内镜下泪囊鼻腔造口术治疗慢性泪囊炎的效果,探讨影响手术疗效的相关因素。方法对35例(38眼)慢性泪囊炎患者行鼻内镜下泪囊鼻腔造口术,所有患者术中制作、保留鼻腔泪囊黏膜瓣,不放置扩张管。术后应用激素喷鼻;门诊随访时,在内镜下进行清创及泪道冲洗。结果术后13～48个月,平均(29.2±9.6)个月,随访到32例(35眼),失访3例(3眼),手术有效率为91.4%(32/35)。所有手术均无并发症。结论鼻内镜下泪囊鼻腔造口术疗效满意。术中充分暴露泪囊、保留黏膜瓣是保证手术成功的关键;定期随访清创可促进黏膜健康愈合;及时发现并处理严重的瘢痕挛缩,可提高疗效。(中国眼耳鼻喉科杂志,2011,11:298-300)     

两种联合手术治疗慢性泪囊炎合并上泪道阻塞的疗效比较

目的:观察两种联合手术治疗慢性泪囊炎合并上泪道阻塞的疗效.方法:慢性泪囊炎合并上泪道阻塞患者68例68眼,采用随机数字表法分为A组和B组,每组34例.A组采用鼻内镜下泪囊鼻腔吻合联合硅胶管置入术.B组采用传统泪囊鼻腔吻合联合硅胶管置入术,所有患者均随访1a.结果:A组患者治疗总有效率为82%,B组为79%,两组比较差异无统计学意义(P>0.05).A组术后面部肿胀发生率为6%、面部瘢痕发生率为0,B组分别为47%、100%,A组并发症的发生率明显低于B组,两组比较差异均有统计学意义(P<0.05).A组患者满意度为82%,B组为59%,A组明显优于B组,两组比较差异有统计学意义(P<0.05).结论:鼻内镜下泪囊鼻腔吻合联合硅胶管置入术安全性高,损伤小,且术后并发症少,患者满意度高,是治疗慢性泪囊炎合并上泪道阻塞比较理想的手术方法.     

鼻内窥镜下泪囊鼻腔造孔术治疗慢性泪囊炎

目的探讨经鼻内窥镜泪囊鼻腔造孔术治疗慢性泪囊炎的方法与临床效果。方法对慢性泪囊炎23例（25眼）采用鼻内窥镜下泪囊鼻腔造孔术并同期处理相应鼻部疾病,术后随访。结果术后随访6～24个月,治愈22眼,好转3眼。结论鼻内窥镜下泪囊鼻腔造孔术损伤小,面部无瘢痕,并能同时处理鼻部疾病,防止吻合口粘连,是治疗慢性泪囊炎的一种有效方法。术后加强换药随访是治愈的关键。     

泪囊鼻腔造孔术后远期闭锁与鼻泪管复通现象

目的：报告275例(310只眼)慢性泪囊炎接受鼻内镜下经鼻行泪囊鼻腔造孔术治疗后，9只眼患者自然泪道复通现象。方法：275例(310只眼)慢性泪囊病变患者接受鼻内镜下泪囊鼻腔造孔术，手术在局部或全身麻醉下进行。术后随访包括鼻内镜检查处理、泪道冲洗及鼻腔局部应用糖皮质激素。结果：随访3～60个月，治愈率75．3％，好转率11．7％，总有效率为87．0％，无效为13．0％。275例(310只眼)中，9只眼术后1年泪囊鼻腔造孔瘢痕闭锁，冲洗液自泪囊鼻腔自然开口流出。结论：慢性泪囊炎泪道下端阻塞并非完全不可逆，在手术造孔、建立泪液旁路引流途径之后，原来阻塞的鼻泪管局部粘膜炎症可以缓解。重新发挥泪液排出功能。     

The Dacryocystorhinostomy Ostium Granulomas: Classification,Indications for Treatment,Management Modalities and Outcomes

Aim: Ostium granulomas following dacryocystorhinostomy (DCR) have not been studied in detail previously. This study aims to classify the DCR-related granulomas based on their ostial locations and to assess the outcomes of their management.

Methods: A retrospective consecutive case series of 47 ostial granulomas evaluated over a period of 2 years were included in this study. All patients underwent detailed endoscopic examination to assess the granuloma locations and their response to initial topical steroids treatment. Persistent granulomas either underwent further management with excision or intralesional steroids based on their location. Patients were followed up for a minimum of 6 months. The primary outcome measure was resolution of granuloma.

Results: The mean age at presentation was 45 years with a female preponderance (68%). 70% (33/47) of granulomas were following external DCR and 30% (14/47) occurred in the setting of endonasal DCR. The most common location was an edge granuloma in 46.8% (22/47) followed by a combined granuloma in 21.2% (10/47). 91.4% (43/47) underwent initial treatment with topical nasal steroids. The remaining 4 (8.5%) underwent primary excision. Among those treated with topical steroids (n?=?43), 9.3% (4/43) underwent further treatment with intralesional triamcinolone. Overall, 4.2% (2/47) recurred in 6 weeks following resolution and were treated with excision.

Conclusion: We recommend routine endoscopic evaluation of all the DCR ostia. Detection of granulomas in early stages and appropriate management as per guidelines proposed may aid in better outcomes.     

Spherical Headed Silicone Intubation in the Treatment of 26 Cases (31 eyes) of Chronic Dacryocystitis under Nasal Endoscopy

 Purpose:To observe the clinical efficacy of spherical headed silicone implantation in the treatment of chronic dacryocystitis under nasal endoscopy. Methods:Twenty six patients (31 eyes) with chronic dacryocystitis were subjected to spherical headed silicone implantation under topical anesthesia (lacrimal passage and nasal mucosal surface). Lacrimal passage irrigation was performed daily throughout the first postoperative week , and once each month thereafter. Results:All spherical headed silicone tube placements were successfully performed. The operative time ranged from 6 to 11 minutes. Symptoms of epiphora were immediately ameliorated post-operatively, and irrigation demonstrated patency of the lacrimal system in all patients. All patients were followed from 7 to 24 months, during which symptoms of tearing were improved. The lacrimal ducts of 27 eyes (87．7%) were normal. The lacrimal ducts of 4 others (12．3%) were still blocked. Lacrimal passage irrigation was open and secretion disappeared in 28 eyes (90.3%). Tearing was observed in 3 eyes (9.68%). Conclusion:Spherical headed silicone tube implantation under nasal endoscopy is successful in relieving symptoms of tearing     

经鼻内窥镜下扩展性骨窗伴高位造口行泪囊鼻腔吻合术治疗慢性泪囊炎

目的:探讨经鼻内窥镜下扩展性骨窗伴高位造口行泪囊鼻腔吻合术(DCR)治疗慢性泪囊炎的疗效及安全性。方法:回顾性临床研究。选取本院2018-01/2020-01确诊为慢性泪囊炎患者50例59眼。根据手术方式分为两组：单纯造口组23例29眼采用经鼻内镜下平中鼻甲腋行DCR(即单纯造口术),改良组27例30眼采用经鼻内镜下扩展性骨窗伴高位造口行DCR。比较两组患者的临床总有效率、术后并发症发生率以及满意率的情况。结果:术后12mo,单纯造口组有效率为79%,改良组为97%(P=0.039)。而单纯造口组并发症总发生率为28%,改良组为7%(P=0.042)。且单纯造口组满意率为65%,改良组为93%(P=0.030)。结论:采用经鼻内镜扩展性骨窗伴高位造口DCR治疗慢性泪囊炎,可提升手术的有效率,降低并发症发生率。     

鼻内镜下鼻腔泪囊吻合术治疗急性泪囊炎的疗效

目的：探讨鼻内镜下鼻腔泪囊吻合术治疗急性泪囊炎的临床疗效。 方法：回顾分析2008-07/2010-07收治的15例15眼行鼻内镜下鼻腔泪囊吻合术的急性泪囊炎患者的临床资料。 结果：患者15例15眼中,治愈13眼,好转1眼,无效1眼,有效率93％ 。 结论：鼻内镜下鼻腔泪囊吻合术治疗急性泪囊炎可以缩短病程,临床切实可行。